Pharma industry denies it lobbied for medicines to move to DG Enterprise

Author (Person)	Jacobsen, Henriette
Series Title	EurActiv
Series Details	29.09.14
Publication Date	29/09/2014
Content Type	News
	The European Commission President Jean-Claude Juncker defended in September 2014 his decision to shift the health technology and pharmaceutical policy services back to the more lobby-friendly internal market directorate. Such move had been criticised by MEPs and NGOs. For its side, the European Federation of Pharmaceutical Industries and Associations (EFPIA) denied it had influenced Mr Juncker's decision.
Source Link	Link to Main Source http://www.euractiv.com/sections/health-consumers/pharma-industry-denies-it-lobbied-medicines-move-dg-enterprise-308777
Related Links	ESO: Background information: Towards the Juncker Commission http://www.europeansources.info/record/towards-the-juncker-commission/ EUObserver, 30.0914: Juncker defends lobby-friendly restructuring of commission services http://euobserver.com/institutional/125802
Subject Categories	Business and Industry, Politics and International Relations
Countries / Regions	Europe